MPS Pharmaa

Healthcare

531686 BSE

BSE: 531686 Pharmaceuticals

₹2.08

Close · 26 Oct 2026

P/E: Not meaningful: loss-making over the last twelve months

View as Markdown

MCP

Close 26 Oct 2026 ₹2.08 +0.24 +13.0% since 10 Nov 2025

Start ₹1.84

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare

Price-based figures at the 26 Oct 2026 close · EPS basis: Standalone · TTM

ROCE: −13.10%
Debt to Equity: Not meaningful: the figure is far outside this ratio’s usual range, as its base is close to zero
EPS (TTM): −₹0.56
Book Value: ₹0.04

Market Cap: —
P/E (TTM): Not meaningful: loss-making over the last twelve months
P/B: 52.00
ROE: −177.00%
Dividend Yield: 0.00%
EBITDA: −₹90.00 L
52W High: ₹2.08
52W Low: ₹1.57

Key Insights

No strengths listed

Weaknesses

Stock is trading at 56.8 times its book value
Company has low interest coverage ratio.
Promoter holding is low: 35.9%
Company has a low return on equity of -61.4% over last 3 years.
Company might be capitalizing the interest cost

Technical Indicators

Technical signals: verdict and indicator counts
Group	Signal	Bearish	Neutral	Bullish
Overall	Bearish	9	2	8
Oscillators	Bearish	4	2	3
Moving Averages	Neutral	5	0	5

Oscillators

Bearish

Neutral

Bullish

Overall

Bearish

Neutral

Bullish

Moving Averages

Neutral

Bearish

Neutral

Bullish

Key readings

RSI (14): 68.32; Neutral
MACD (12,26,9): 0.05; Bullish
SMA (50): 1.90; Bullish
SMA (200): 2.54; Bearish

As of 26 Oct 2026, the latest day with price data, so these readings are not current.

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y	−100.00%
5Y	Zero base
3Y	Zero base
1Y	Zero base
TTM	Zero base

Net profit

Net profit growth by window
10Y	Loss narrowed by ₹0.17 Cr
5Y	Loss narrowed by ₹3.40 Cr
3Y	Loss narrowed by ₹0.03 Cr
1Y	Loss widened by ₹0.12 Cr
TTM	Loss widened by ₹0.15 Cr

Operating cash flow

Operating cash flow growth by window
10Y	Turned negative
5Y	Outflow narrowed by ₹0.34 Cr
3Y	Outflow narrowed by ₹0.28 Cr
1Y	Outflow widened by ₹0.02 Cr
TTM	—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y	No sales
5Y	No sales
3Y	No sales
1Y	No sales
TTM	No sales

Revenue by year

Revenue by year, ₹ crore
Mar 2017	₹2.84 Cr
Mar 2018	₹4.09 Cr
Mar 2019	₹0.83 Cr
Mar 2020	₹0.00 Cr
Mar 2021	₹0.00 Cr
Mar 2022	₹0.03 Cr
Mar 2023	₹0.00 Cr
Mar 2024	₹0.00 Cr
Mar 2025	₹0.00 Cr
Mar 2026	₹0.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017	−₹7.39 Cr
Mar 2018	−₹0.87 Cr
Mar 2019	−₹1.25 Cr
Mar 2020	−₹1.17 Cr
Mar 2021	−₹4.42 Cr
Mar 2022	−₹0.14 Cr
Mar 2023	−₹1.05 Cr
Mar 2024	−₹0.83 Cr
Mar 2025	−₹0.90 Cr
Mar 2026	−₹1.02 Cr

Quarterly Results

₹ Cr

531686 quarterly results, ₹ crore
Particulars	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0	0	0	0	0	0	0	0	0	0	0	0	0
Expenses	0.19	0.21	0.18	0.21	0.19	0.19	0.18	0.19	0.19	0.19	0.19	0.37	0.2
Operating Profit	−0.19	−0.21	−0.18	−0.21	−0.19	−0.19	−0.18	−0.19	−0.19	−0.19	−0.19	−0.37	−0.2
Other Income	0.03	0.06	0	0	0	0	0.04	0	0	0	0	0.04	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04
PBT	−0.2	−0.19	−0.22	−0.25	−0.23	−0.23	−0.18	−0.23	−0.23	−0.23	−0.23	−0.37	−0.24
Tax %	−5%	−5.26%	−4.55%	0%	−4.35%	−4.35%	0%	21.74%	−4.35%	−4.35%	−4.35%	−2.7%	0%
Net Profit	−0.19	−0.18	−0.21	−0.24	−0.22	−0.22	−0.17	−0.28	−0.22	−0.22	−0.22	−0.36	−0.24
EPS (₹)	−0.1	−0.09	−0.11	−0.13	−0.12	−0.12	−0.09	−0.15	−0.12	−0.12	−0.12	−0.19	−0.13

Profit & Loss

₹ Cr

531686 profit and loss, annual, ₹ crore
Particulars	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	12.24	1.35	2.84	4.09	0.83	0	0	0.03	0	0	0	0	0
Expenses	11.43	1.84	9.72	4.62	1.56	0.67	4.14	0.71	0.95	0.8	0.77	0.95	0.95
Operating Profit	0.81	−0.49	−6.88	−0.53	−0.73	−0.67	−4.14	−0.68	−0.95	−0.8	−0.77	−0.95	−0.95
OPM %	6.62%	−36.3%	−242.25%	−12.96%	−87.95%	—	—	Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.	—	—	—	—	—
Other Income	0	0	0.03	0.06	0.02	0.01	0.2	0.26	0.02	0.09	0.05	0.04	0.04
Interest	1.08	0.08	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0.65	0.62	0.59	0.59	0.59	0.57	0.56	0.51	0.15	0.15	0.15	0.15	0.16
PBT	−0.92	−1.19	−7.44	−1.06	−1.3	−1.23	−4.5	−0.93	−1.08	−0.86	−0.87	−1.06	−1.07
Tax %	−26.09%	−0.84%	−0.81%	−17.92%	−3.85%	−5.69%	−1.78%	−84.95%	−1.85%	−2.33%	3.45%	−3.77%	—
Net Profit	−0.68	−1.19	−7.39	−0.87	−1.25	−1.17	−4.42	−0.14	−1.05	−0.83	−0.9	−1.02	−1.04
EPS (₹)	−0.45	−0.62	−3.87	−0.46	−0.65	−0.61	−2.31	−0.07	−0.55	−0.43	−0.47	−0.53	−0.56
Div. Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	—

Balance Sheet

₹ Cr

531686 balance sheet, annual, ₹ crore
Particulars	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	15.03	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11
Reserves	4.17	−0.13	−7.5	−8.35	−9.58	−10.75	−15.16	−15.29	−16.32	−17.14	−18.03	−19.04
Borrowings	7.78	6.65	2.9	2.9	2.51	2.53	5.68	5.81	6.77	7.27	7.46	7.52
Other Liabilities	5.38	2.94	6.41	5.49	5.52	5.52	1.67	0.53	0.63	0.7	0.8	0.88
Total Liabilities	32.36	28.57	20.92	19.15	17.56	16.41	11.3	10.16	10.19	9.94	9.34	8.47
Fixed Assets	8.21	7.64	7.06	6.47	5.88	5.26	4.68	4.17	4.14	4.01	3.83	3.66
CWIP	6.15	6.15	5.51	5.21	5.43	5.02	3.9	3.42	3.4	3.26	2.91	2.41
Investments	0.92	0.92	0.92	0.92	0.92	0.92	0.54	0.54	0.54	0.54	0.54	0.54
Other Assets	17.08	13.86	7.43	6.55	5.33	5.21	2.18	2.03	2.11	2.13	2.06	1.86
Total Assets	32.36	28.57	20.92	19.15	17.56	16.41	11.3	10.16	10.19	9.94	9.34	8.47

Cash Flow

₹ Cr

531686 cash flow, annual, ₹ crore
Particulars	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating	2.16	1.25	0.37	−0.34	0.61	−0.49	−0.93	−4.34	−0.87	−0.63	−0.57	−0.59
Investing	−0.44	−0.05	0.63	0.3	−0.22	0.46	1.54	0.46	−0.1	0.12	0.38	0.52
Financing	−1.75	−1.19	−0.98	0	−0.39	0.03	−0.61	3.88	0.96	0.51	0.18	0.07
Net Cash Flow	−0.03	0.01	0.02	−0.04	0	0	0	0	−0.01	0	0	0
Free Cash Flow	1.72	1.2	1	−0.04	0.39	−0.04	0.22	−3.88	−0.97	−0.51	−0.19	−0.07
CFO/OP	267	−292	−5	64	−84	73	22	638	92	79	74	62

Ratios

531686 financial ratios, annual
Particulars	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	229	1,154	532	344	1,148	—	—	365	—	—	—	—
Inventory Days	274	6,544	50.05	58.94	254	—	—	4,015	—	—	—	—
Days Payable	123	556	15.95	14.48	71.22	—	—	876	—	—	—	—
Cash Conversion Cycle	380	7,142	566	389	1,330	—	—	3,504	—	—	—	—
Working Capital Days	209	1,725	−116	−87.46	−849	—	—	Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.	—	—	—	—
ROCE %	0.58%	−4.22%	−37.07%	−7.53%	−10.12%	−10.73%	−45.61%	−9.66%	−11.26%	−9.15%	−9.79%	−13.14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

62 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

Public 37.94%
Promoters 35.89%
Others 25.59%
DIIs 0.58%

16.04% of promoter holding pledged as of 14 Oct 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about MPS Pharmaa

What does MPS Pharmaa Ltd do?

Incorporated in 1997, MPS Pharmaa Ltd manufactures and sells pharmaceutical products

Where is MPS Pharmaa Ltd (ADVIKLA) listed?

MPS Pharmaa Ltd trades under code 531686 on the BSE.

Which sector does MPS Pharmaa Ltd belong to?

MPS Pharmaa Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.

What is the 52-week high and low of MPS Pharmaa Ltd?

Over the last 52 weeks MPS Pharmaa Ltd has traded between ₹1.57 and ₹2.08 as of 26 Oct 2026.

What is the Return on Equity (ROE) of MPS Pharmaa Ltd?

MPS Pharmaa Ltd reported a return on equity of -177.00%.

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531686.md for MPS Pharmaa Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List FII and DII flows, month by month How Tapetide Scores changed, month by month Stocks mutual funds are buying, month by month

MPS Pharmaa

Key Fundamentals

Key Insights

Weaknesses

Technical Indicators

Oscillators

Overall

Moving Averages

Key readings

Growth Rate

Revenue

Net profit

Operating cash flow

Operating margin· change in pp

Revenue by year

Net profit by year

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Insights

Shareholding Pattern

Documents

Frequently Asked Questions about MPS Pharmaa

Company Information

For AI agents and developers

Explore More